We view Alzheimer’s medications as tactical tools within a broader care strategy. While these therapies do not stop the disease, they may be valuable for:
Symptom Management: Optimizing comfort to improve daily engagement.
Functional Longevity: Helping eligible patients retain independence and function for as long as possible.
Stability & Safety: Creating a predictable, secure environment for both the patient and caregiver.
We will begin by evaluating the efficacy and side-effect profiles of standard treatments to ensure they align with your specific health goals.

Hidden Risks: Medications That May Be Harming Your Memory
The Supplement Guide: What Actually Works vs. What’s a Waste of Money
Modern Treatments: Understanding Newer Antibody Therapies
Better Rest: Safe Strategies for Behavior & Sleep Management
Your Questions Answered: FAQs on Treatment & Outcomes
Investment & Access: Clear Details on Costs and Insurance Coverage
Pharmacist Support: Expert Guidance to Ensure Your Safety on Your Journey to Better Health

Some medications — especially when used long-term or in combination — are associated with increased risk of cognitive decline, delirium, or worsening memory.
This does not mean everyone should stop these medications.
It means they deserve thoughtful review.
As a pharmacist trained in complex medication management, I carefully evaluate cognitive risk, anticholinergic burden, dosing, duration, and safer alternatives when appropriate.
Here are the categories I prioritize:
Anticholinergic drugs block acetylcholine — a key neurotransmitter involved in memory and learning. Higher cumulative “anticholinergic burden” is associated with increased dementia risk in multiple studies.
exposure, the greater the associated risk.

Common high-risk examples include:
Research consistently shows a dose-dependent relationship — the higher the cumulative exposure, the greater the associated risk.
Some alternatives (such as trospium for bladder symptoms or second-generation antihistamines like cetirizine or loratadine) may carry lower cognitive impact.

Medications such as:
Alprazolam (Xanax®)
Lorazepam (Ativan®)
Clonazepam (Klonopin®)
Z-drugs like zolpidem (Ambien®)
have been associated with:
Memory impairment
Increased fall risk
Delirium
Dose-dependent increased dementia risk in some studies
These medications are sometimes appropriate short-term. But long-term use deserves careful reassessment— especially in adults over 65.

The relationship between antidepressants and cognition is complex. Tricyclic antidepressants with strong anticholinergic effects pose higher risk.
Evidence on other SSRIs is mixed and may depend on the individual, dose, and underlying diagnosis. Paroxetine carries more anticholinergic burden than other SSRIs.
Cognitive decline is rarely caused by one medication alone, but cumulative exposure, polypharmacy, and unrecognized anticholinergic burden can quietly contribute over time. This is why we never look at medications in isolation, but evaluate total burden, symptom history, and overall risk profile.

Supplements are one of the most common—and most confusing—parts of Alzheimer’s care.
It’s easy to assume more is better.
In reality, most supplements offer little benefit unless they are targeted to a specific need.
In this work, we don’t build long supplement lists.
We ask:
“What does this person actually need?”
Because supplements are most effective when they:

Vitamin D
B Vitamins (B12, Folate, B6)
Omega-3s (EPA/DHA)
Takeaway: These can be helpful—but only when personalized and monitored.

These medications increase neurotransmitter levels, enhancing cognitive function and daily alertness. Optimal efficacy requires timely initiation paired with lifestyle modifications.
Donepezil (Aricept®), Galantamine (Razadyne®), Ivastigmine (Exelon®)
🔘 Discover whether these medications are a good fit for your situation — and the critical questions to ask before starting.

Monoclonal antibodies are a newer class of medications designed to target and help clear amyloid plaques in the brain — one of the hallmark features of Alzheimer’s disease. They aim to slow disease progression in carefully selected individuals, particularly in the earliest stages of cognitive decline.
Lecanemab (Leqembi®), Donanemab (Kisunla™)
Important considerations before starting:
🔘 Get a clear breakdown of the real-world benefits, risks, and limitations behind these medications.

These medications do not slow Alzheimer’s disease progression, but may help manage agitation or sleep disruption when symptoms affect safety or quality of life.
Brexpiprazole (Rexulti®) is FDA-approved to treat agitation associated with dementia due to Alzheimer’s disease, including restlessness, irritability, or aggressive behaviors.
It works by modulating dopamine and serotonin activity in the brain. This medication is typically considered when non-drug strategies are not enough and requires careful monitoring due to known safety risks in older adults.

Suvorexant (Belsomra®) is used to treat difficulty falling or staying asleep, a common challenge in Alzheimer’s disease.
Unlike traditional sedatives, it works by blocking orexin, a wake-promoting brain chemical. Studies including people with Alzheimer’s show improved total sleep time, which may support daytime function and caregiver well-being.
Medications for agitation or sleep are supportive tools, not first-line Alzheimer’s treatments. They are most appropriate when symptoms interfere with safety, daily care, or caregiver strain.
🔘 Learn more about sleep treatments and safety considerations

Alzheimer’s treatment costs vary widely depending on therapy type, disease stage, and insurance coverage.
Traditional medications are often low-cost generics and may be covered by insurance.
Newer biologic therapies can involve high annual costs, along with required imaging and infusion services.
Coverage varies by diagnosis, stage, and payer.

For those seeking deeper, personalized guidance, optional self-pay services may include:
The goal is clearer decisions — not more complexity.

In early stages, some medications may lead to subtle improvements in attention, focus, or daily functioning within weeks to a few months. Other treatments aim primarily to slow progression, which may not feel immediately noticeable.
Lifestyle strategies — such as improving nutrition, sleep, physical activity, and stress management — may support energy, mood, or daily routines within weeks, while brain-related benefits tend to build over several months. The greatest benefit is often seen when medication care and lifestyle changes are combined early.
In later stages, treatments are less likely to improve memory but may help support behavior, comfort, and daily function. Benefits may include reduced agitation, improved routines, or better tolerance of daily care.
Lifestyle and environmental strategies can still be meaningful, particularly for:
In later stages, success is often measured by quality of life rather than cognitive improvement.
No. Response varies widely based on:
This variability is why treatment plans benefit from ongoing review and individualization rather than a one-size-fits-all approach.
Yes. Alzheimer’s care is dynamic. Medications, doses, and lifestyle strategies may be adjusted as symptoms, goals, or side effects change.
Regular reassessment helps ensure that treatment continues to offer benefit without unnecessary burden — especially as care priorities evolve over time.
Yes. Evidence supports combining medication management with evidence-based lifestyle and supportive strategies at all stages of Alzheimer’s.
While lifestyle changes are not a cure, they may help:
Medication and lifestyle strategies are complementary, not competing — and together often provide the most practical benefit.

If you’re unsure whether current medications are helping — or possibly harming — it’s time for clarity.
As a board-certified pharmacist trained in complex medication management and the ReCODE Protocol, I provide structured, expert review to ensure every prescription supports cognitive goals.
In a focused consultation, we will:
The objective is simple: fewer blind spots, better strategy, and measurable impact.
When we reduce unnecessary pills and optimize whats most warranted, we often see:
Improved clarity
Better energy
Reduced fall risk
Improved sleep
Greater confidence for both patient and caregiver
If you’re ready for a coordinated plan instead of guesswork, schedule your consultation today.
🔘Download Organization Tips: How to Simplify Your Daily Meds & Supplements